Losartan Did Not Significantly Lower Hepatic Inflammation in Children With NAFLD
Losartan, an angiotensin II receptor blocker, does not significantly affect the amount of hepatic inflammation and injury in children with nonalcoholic fatty liver disease (NAFLD), [Read More]
Read More